- 1、本文档共3页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
WHOgoodmanufacturingpracticesforpharmaceuticalproducts:mainprinciples.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.Forty-eightReportGeneva,WorldHealthOrganization,2014(WHOTechnicalReportSeries,No.986),Annex2.
Shortname:WHOTRSNo.986,Annex2
/medicines/areas/quality_safety/quality_assurance/expert_committee/trs_986/en/
WHOGoodManufacturingPractices:waterforpharmaceuticaluse.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.Fourth-sixReport.Geneva,WorldHealthOrganization,2012(WHOTechnicalReportSeries,No.970),Annex2
Shortname:WHOTRSNo.970,Annex2
/medicines/areas/quality_safety/quality_assurance/expert_committee/trs_970/en/
WHOTRSNo.1033,Annex3WHOgoodmanufacturingpractices:waterforpharmaceuticaluse(上面的应该不是最新的,确认下1033应该是最新的)
WHOguidelinesforsamplingofpharmaceuticalproductsandrelatedmaterials.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.Thirty-ninthReport.Geneva,WorldHealthOrganization,2005(WHOTechnicalReportSeries,No.929),Annex4
Shortname:WHOTRSNo.929,Annex4
/trs/WHO_TRS_929_eng.pdf?ua=1
Supplementaryguidelinesongoodmanufacturingpractices:validation.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.FortiethReport.Geneva,WorldHealthOrganization,2006(WHOTechnicalReportSeries,No.937),Annex4
Shortname:WHOTRSNo.937,Annex4
/trs/WHO_TRS_937_eng.pdf?ua=1
WHOGoodPracticesforPharmaceuticalQualityControlLaboratories.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.Forty-fourthReport.Geneva,WorldHealthOrganization,2010(WHOTechnicalReportSeries,No.957,Annex1
Shortname:WHOTRSNo.961,957),Annex1
/medicines/publications/44threport/en/
WHOGoodPracticesforPharmaceuticalProductsContainingHazardousSubstances.WHOExpertCommitteeonSpecificationsforPharmaceuticalPreparations.Forty-fourthRep
您可能关注的文档
- 13、WHO关于预认证疫苗产品变更的指南-2015.pdf
- 13、参考-WHO 预认证产品变更常见问题解答-FAQ_Variations-中英-2020 .pdf
- 13、WHO_TRS_981 附录3:WHO关于预认证产品变更的指南-英-2013.pdf
- 12、WHO_TRS_981附录2:WHO质量风险管理指南-英-2013.pdf
- 2、WHO_TRS_970 附录2:WHO药品生产质量管理规范:制药用水-中-2012年(准).pdf
- 3、WHO_TRS_929 附录4WHO 关于药品和相关物料的抽样指导原则-2005年(准).pdf
- 16、WHO_TRS_992 附录5的附件14:WHO_TRS_961 Annex9 补充文件14_运输路线概况确认-2014.pdf
- CDE-20030320-细胞培养用牛血清生产和质量控制技术指导原则-现行.doc
- CDE-20180911-药品审评中心临床试验期间药物警戒系统Gateway方式提交步骤及申请表-现行.doc
- CDE-20181221-药品注册审评一般性技术问题咨询管理管理规范-现行.doc
文档评论(0)